Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration

被引:45
|
作者
Roh, Miin [1 ]
Selivanova, Alexandra [1 ]
Shin, Hyun Joon [2 ]
Miller, Joan W. [1 ]
Jackson, Mary Lou [3 ]
机构
[1] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA
[2] Harvard Med Sch, Dept Med, VA Boston Hlth Care syst, Div Aging,Brigham & Womens Hosp, Boston, MA USA
[3] VGH Univ British Coumbia, Eye Care Ctr, Vancouver, BC, Canada
来源
PLOS ONE | 2018年 / 13卷 / 05期
关键词
FUNCTION QUESTIONNAIRE; ASSOCIATION; DISABILITY; VALIDITY; THERAPY;
D O I
10.1371/journal.pone.0196481
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. Methods We retrospectively reviewed 47 patients (mean age 83.2 years) with bilateral advanced AMD. Clinical assessment included age, gender, type of AMD, high contrast visual acuity (VA), history of medical conditions, contrast sensitivity (CS), central visual field loss, report of Charles Bonnet Syndrome, current treatment for AMD and Rasch-calibrated NEI VFQ-25 visual function and socioemotional function scales. The NEI VFQ visual function scale includes items of general vision, peripheral vision, distance vision and near vision-related activity while the socioemotional function scale includes items of vision related-social functioning, role difficulties, dependency, and mental health. Multiple regression analysis (structural regression model) was performed using fixed item parameters obtained from the one-parameter item response theory model. Results Multivariate analysis showed that high contrast VA and CS were two factors influencing VRQoL visual function scale (beta = -0.25, 95% CI-0.37 to -0.12, p<0.001 and beta = 0.35, 95% CI 0.25 to 0.46, p<0.001) and socioemontional functioning scale (beta = -0.2, 95% CI -0.37 to -0.03, p = 0.023, and beta = 0.3, 95% CI 0.18 to 0.43, p = 0.001). Central visual field loss was not assoicated with either VRQoL visual or socioemontional functioning scale (beta = -0.08, 95% CI-0.28 to 0.12,p = 0.44 and beta = -0.09, 95% CI -0.03 to 0.16, p = 0.50, respectively). Conclusion In patients with vision impairment secondary to bilateral advanced AMD, high contrast VA and CS are two important factors affecting VRQoL.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Visual acuity and fixation characteristics in age-related, macular degeneration
    Cacho, Isabel
    Dickinson, Christine M.
    Reeves, Barnaby C.
    Harper, Robert A.
    OPTOMETRY AND VISION SCIENCE, 2007, 84 (06) : 487 - 495
  • [42] Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration
    Merry, Graham F.
    Munk, Marion R.
    Dotson, Robert S.
    Walker, Michael G.
    Devenyi, Robert G.
    ACTA OPHTHALMOLOGICA, 2017, 95 (04) : E270 - E277
  • [43] An interpretation of quality of life based on binocular visual acuity in German patients with age-related macular degeneration
    Pleil, AM
    Cappelleri, J
    Chisholm, JA
    Getter, CA
    Lustig, S
    Reichel, MB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U545 - U545
  • [44] Association of Lesion Location and Functional Parameters with Vision-Related Quality of Life in Geographic Atrophy Secondary to Age-related Macular Degeneration
    Kuenzel, Sandrine H.
    Broadbent, Eliza
    Moeller, Philipp T.
    Lindner, Moritz
    Goerdt, Lukas
    Czauderna, Joanna
    Schmitz-Valckenberg, Steffen
    Holz, Frank G.
    Pfau, Maximilian
    Fleckenstein, Monika
    OPHTHALMOLOGY RETINA, 2024, 8 (08): : 794 - 803
  • [45] Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life
    Ahluwalia, Aneesha
    Shen, Liangbo L.
    Del Priore, Lucian, V
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (02) : 307 - 316
  • [46] The effects of loading ranibizumab on vision-related quality of life in the treatment of low-risk neovascular age-related macular degeneration
    Daldal, Hatice
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2022, 14
  • [47] The impact of typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy on vision-related quality of life in Asian patients
    Fenwick, Eva K.
    Cheung, Chui Ming Gemmy
    Ong, Peng Guan
    Tan, Gavin
    Lee, Shu Yen
    Yeo, Ian
    Cheng, Ching Yu
    Wong, Tien Y.
    Lamoureux, Ecosse L.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (05) : 591 - 596
  • [48] Geographic atrophy secondary to age-related macular degeneration: Significance of lesion location and functional determinants to vision-related quality of life
    Broadbent, Eliza Eliza
    Kuenzel, Sandrine H.
    Moeller, Philipp
    Linder, Moritz
    Goerdt, Lukas
    Czauderna, Joanna
    Schmitz-Valckenberg, Steffen
    Holz, Frank G.
    Pfau, Maximilian
    Fleckenstein, Monika
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [49] Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
    Inoue, Maiko
    Arakawa, Akira
    Yamane, Shin
    Kadonosono, Kazuaki
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 1711 - 1716
  • [50] Vision with age-related macular degeneration
    Valberg, A.
    Fosse, P.
    PERCEPTION, 1997, 26 : 37 - 37